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SUMMARY 
Primary human skin fibroblasts are an accessible source of phenotypically and karyotypically normal human 
cells, but are difficult to transfect with exogenous DNA. Here we demonstrate that both transient expression 
and stable transformation can be carried out by the method of electroporation. Highly efficient transient 
chloramphenicol acetyltransferase expression was shown after transfection with plasmid pRSVCAT. Stable 
transformation of human skin libroblasts to G418 resistance was obtained after electroporation with neo- 
containing plasmids at an efficiency of approximately 1.4 x 10 - 5/pg DNA. The ability to easily transfect these 
cells with exogenous DNA may have important applications in the study of human genetic diseases and cancer. 
INTRODUCTION 
Starting with the first successful transformation of 
human cells by Szybalska and Szybalski (1962), 
several methods of transfection have been devised 
for the insertion of cloned DNAs into cells. One of 
the most common methods, calcium phosphate co- 
precipitation, is quite variable in efficiency from one 
cell line to another (German et al., 1983). Many of 
the most transfectable human cell lines are derived 
from tumor tissues or have been tranformed bv SV40 
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viral or plasmid DNAs (Boggs et al., 1986; Canaani 
Medical Center Drive, Ann Arbor, MI48109-0650 (U.S.A.) 
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properties such as continuous growth, altered cell 
morphology, and aberrant chromosomal composi- 
tion that are not found in primary cell cultures pro- 
duced from normal tissues and are undesirable for 
some applications. In general, these cell lines are ten- 
to lOO-fold more transfectable than primary cell cul- 
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tures (Canaani et al., 1986; Murnane et al., 1985; 
Wood et al., 1987). 
A large number of studies are being performed 
today whose ultimate goals are to draw conclusions 
about the causes of human cancer. A continuous 
search goes on for an in vitro cell system that most 
closely resembles the in vivo situation found in man. 
Optimally, one would like to study the effects of 
oncogenes in primary human cells such as HSFs. 
Furthermore, studies of human genetic diseases, 
such as familial polyposis of the colon or von 
Hippel-Lindau syndrome, would be aided by the 
ability to transfect exogenous DNA into HSFs de- 
rived from patients with these rare disorders. Up till 
now, however, stable transformation of HSFs by 
DNAs other than SV40 has been demonstrated in a 
limited number of studies (Chang et al., 1986; 
Diatloff-Zito et al., 1986; Doniger et al., 1983; 
Mayne et al., 1986; Shaham et al., 1987, Shimada 
et al., 1987). Several investigators have been suc- 
cessful in transfecting human foreskin libroblasts 
(Fry et al., 1986; Hurlin et al., 1987, Pirisi et al., 
1987; Sager et al., 1983; Sutherland and Bennett, 
1984). Whether or not transfection efficiencies are 
comparable between foreskin and epidermal skin 
libroblasts is unclear. In addition, HSFs are easily 
obtainable from patients whereas foreskin or fetal 
tibroblasts are not available for use in studies 
involving most genetic diseases. 
Electroporation has been used to successfully 
transfect primary human fetal fibroblasts and a large 
number of immortalized mammalian cultures (Chu 
et al., 1987). Knutson and Yee (1987) alluded to 
successful transfection of HSFs by electroporation 
but did not provide any confirming data. In this 
study, we demonstrate successful transient and 
stable transformation of HSFs using electro- 
poration. 
EXPERIMENTAL AND DISCUSSION 
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Fig. 1. Transient expression of CAT activity in HSFs. 
pRSVCAT was transfected into HSFs obtained from two differ- 
ent normal individuals (lanes 2 and 4). Lanes 1 and 3 contain cell 
extracts from the same individuals that were electroporated 
without pRSVCAT. Cells were harvested 96 h after electropo- 
ration and 80 ~1 of extract (corresponding to an absorbance of 
approx. 0.08 at 280 nm) was incubated with [ “C]chloram- 
phenicol and acetyl coenzyme A overnight. CAT activity was 
measured by thin-layer chromatography as described by Gorman 
et al. (1982b). 
electroporation. This plasmid (50 pg of pRSVCAT) 
was transfected into lo6 to lo7 early passage cells. 
Trypsinized cells and DNA were suspended in 
500 ~1 of PBS and pipetted into alcohol-sterilized 
plastic cuvettes (Sarstedt). As previously described 
by Potter et al. (1984), a 2000 V electrical pulse was 
applied to the suspension with stainless steel elec- 
trodes using an ISCO model 494 electrophoresis 
power supply. Electroporated cells were replated 
into flasks and fed with Eagle’s MEM (Gibco) 
supplemented with 15 y0 FB S (Gibco). After 96 h of 
incubation, transfected HSFs were harvested and 
CAT assays were performed on cell extracts 
according to Gorman et al. (1982b). Results showed 
that HSFs were capable of taking up and expressing 
foreign DNA using the method of electroporation 
(Fig. 1). The level of expression compared favorably 
with that seen in calcium phosphate-transfected 
HeLa cells (not shown). 
(a) Transient expression using pRSVCAT 
(b) Stable integration using pHneo 
Normal HSFs from skin biopsies of adult 
volunteers were transfected with pRSVCAT (Gor- 
man et al., 1982a) in order to determine whether 
these cells were capable of transient expression after 
We also wished to determine whether DNA that 
entered HSFs was capable of becoming integrated 
into the cellular genome. In order to fulfill this goal, 
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we initially transfected HSFs with pHneo. pHneo is 
a vector in which deleterious out-of-frame initiation 
codons within the 5’-untranslated region of the lzeo 
gene have been eliminated (personal communica- 
tion, C.C. Simonsen, In Vitro, San Carlos, CA). The 
pHneo construct provided us with a selectable 
marker for obtaining stably transfected clones. 
Briefly, 2 pg of PvuI-linearized pHneo was sus- 
pended with lo6 to lo7 cells in 500 ~1 of PBS and 
electroporation was performed as described for the 
pRSVCAT transfection. Transfected cells were re- 
plated into petri dishes and fed with 15 % FBS 
MEM. After 48 h, G418 selective medium, con- 
taining 400 pg/ml of active geneticin (Gibco) in 15 % 
FBS MEM, was added to the cultures. Cells were 
maintained in G418 medium for approx. four weeks 
at which time they were assumed to be fully selected 
and were placed back into 15 y0 FB S MEM without 
geneticin. Untransfected HSFs and cells electro- 
porated without DNA survived a maximum of one 
week in G418 medium. Stably transfected clones 
were counted three weeks after transfection and 
DNA was isolated from these clones after about 
eight weeks. 
Fig. 2 shows that by Southern blotting a represen- 
tative number of transfected HSF clones contained 
sequences homologous to the pHneo plasmid. As 
judged by copy controls, the pHneo sequences 
appeared to integrate as concatemers of three to ten 
copies at a single site in the cellular genome. 
(c) Comparison to calcium phosphate method of 
transfection 
Next, we wanted to compare electroporation with 
the calcium phosphate method of transfection. In 
conjunction with this study, we were also interested 
in determining whether transfection efficiencies 
differed between two related vectors, namely pHneo 
and pSV2neo (Southern and Berg, 1982). Electropo- 
ration assays were carried out using molar equiva- 
lents of PvuI linearized pHneo (2pg) and PvuI 
linearized pSV2neo (2.2 pg). Calcium phos- 
phate-DNA co-precipitations were performed using 
a standard protocol (Graham and Van der Eb, 
1973). In these assays, 75 pg of sheared human 
placental DNA was used as carrier along with the 
same quantities of neo DNAs that were utilized for 
the electroporations. A 1-min glycerol shock was 
TABLE I 
Transfection efficiencies for pHneo and pSV2neo in human skin 
fibroblasts 
Plasmid” Transfection efficienciesb 
Electroporation’ Calcium phosphated 
pHneo 
pSV2neo 
0.8 x 10W5 1.0 x 10-e 
1.4 x 1o-5 0.5 x 10-C 
a PvuI linearized plasmids were transfected into HSFs as de- 
scribed in sections b and c. 
b Expressed as colonies/number of transfected cells/pg neo plas- 
mid. 
’ Electroporations were performed as described in section a. 
d Calcium phosphate transfections were performed as described 
in section c. 
performed on the calcium phosphate transfected 
cells 5 h after transfection (Got-man et al., 1983). 
Clones were counted three weeks after the trans- 
fections. Results are summarized in Table I. 
(d) Conclusions and additional observations 
In our hands, electroporation proved to be eight- 
to 28-fold more efficient than calcium phosphate 
transfection of primary HSFs. Jastreboff et al. 
(1987) noted a similar increase in transfection ef- 
ficiency when comparing electroporation to calcium 
phosphate transfection in NIH3T3 cells. In addition, 
we noted that after two weeks in G418 medium, 
electroporated clones were, in general, much larger 
than calcium phosphate-transfected clones. At the 
end of three weeks in selective medium, calcium 
phosphate-transfected clones remained difficult to 
visualize without the aid of a microscope. Possible 
reasons for this observation would include residual 
toxicity from the glycerol shock, growth stimulation 
from the electrical pulse, or more effective expression 
of the G418 resistance gene after electroporation. 
Our results showed that pSV2neo had a slightly 
higher frequency of transformation to G418 resis- 
tence than pHneo. Our electroporation studies with 
pSV2neo yielded a transformation efficiency of 
1.4 x 10W5/pg DNA in HSFs. The efficiency for 
pHneo was 0.8 x 10e5/pg DNA. 
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Fig. 2. Stable transfection of pHneo in HSFs. (Panel A) Analysis of pHneo-transfected clonal DNAs. DNAs isolated from stably 
transformed G418-resistant colonies were restricted with &I, electrophoresed on a 1 y0 agarose gel, and transferred to GeneScreen 
Plus using 0.4 M NaOH. Hybridization was performed using a HindIII-%a1 fragment of pHneo as a probe and following hybridization 
conditions recommended by the manufacturer (NEN) (Davis et al., 1986; Feinberg and Vogelstein, 1983). HSFs were transfected with 
PvuI linearized pHneo, selected in G418 medium [15 y0 FBS MEM containing 400 pg/ml of active geneticin (Gibco)], and picked as 
clones prior to DNA extraction. Lanes l-3 and 5-9 represent individual clones that arose from HSFs transfected with pHneo. In lane 4, 
DNA from untransfected HSFs was used as a negative control. Lanes lo-12 are copy controls which were created by adding 1, 3, or 
10 molar equivalents of circular pHneo to placental DNA before digesting with PstI. All DNAs were restricted with PstI in order to 
visualize the number of insertion sites in each clone. The presence of one additional fragment in each clone is indicative of a single site 
of integration. (Map B) Schematic representation of an integrated copy of pHneo along with the HindIII-SmaI probe used in this 
experiment. The straight lines and boxed-in regions indicate the order of pHneo sequences when this vector is linearized with PvuI and 
the wavy lines represent genomic DNA surrounding the integration site. This probe hybridizes with a constant 0.8-kb PstI fragment 
in each DNA digestion as seen in panel A (lanes 1-3 and 5-12). An additional PstI fragment of variable size is also visualized in clonal 
DNAs (panel A, lanes l-3 and 5-9) depending on where the nearest PstI site lies in genomic DNA upstream of the integration site. 
This variable PstI site is indicated in parentheses. When circular pHneo is digested with PstI, an additional constant fragment of 1.5 kb 
is also present. This fragment is seen in the copy controls (panel A, lanes 10-12). 
We have also successfully co-transfected pHneo that myc expression from the pSV-v-myc vector may 
along with a non-selectable marker which expresses be deleterious to HSF growth. Stevenson and 
the viral myc oncogene, pSV-v-myc (Land et al, Volsky (1986) reported some instability of the 
1983) into HSFs (not shown). Co-transfections pSV-v-myc plasmid when transfecting human lym- 
were performed using a ten-fold excess of pSV-v-myc phocytes using a Sendai virus envelope-mediated 
along with 2 pg of pHneo. Efficiencies were approx. gene transfer technique. In addition, Newbold and 
ten-fold lower for co-transfections than for neo trans- Overell (1983) noted a substantial decrease in the 
fections alone, indicating to us that higher quantities formation of calcium phosphate-transfected colonies 
of DNA may be toxic to the cells. It is also possible when they co-transfected a dihydrofolate reductase 
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plasmid along with a EJras-containing plasmid into 
primary hamster dermal fibroblasts. Thus, certain 
oncogene-expressing plasmids may be deleterious to 
primary cells, regardless of the transfection method 
employed. 
An alternative approach which bypasses these 
co-transfection difficulties is the use of vectors that 
contain both neo and oncogene sequences. We have 
successfully transfected into HSFs a vector that 
contains a 6.6-kb BamHI EJrus insert ligated into a 
Sal1 site of pHneo, at efficiencies of approx. 
0.6 x 10 - 5/pg. In addition, we have been able to 
successfully transfect HSFs using a number of other 
neo- and oncogene-containing constructs obtained 
from M.A. Tainsky (Tainsky et al., 1987). 
In this brief communication, we have demon- 
strated that primary HSFs can be efficiently trans- 
fected by electroporation. We feel electroporation 
offers several advantages over other current methods 
of transfection. First, a relatively small amount of 
DNA is required to transform a large number of cells 
(2 pg/106 to 10’ cells). Second, no carrier DNA is 
required. Third, no toxic substances such as di- 
methylsulfoxide, glycerol, polyethylene glycol, or 
sodium butyrate ever come into contact with the 
cells. And, finally, no labor-intensive procedures are 
involved as in protoplast fusion, nuclear injection, 
lipofection (Felger et al., 1987), and Sendai virus 
envelope-mediated gene transfer techniques. Elec- 
troporation thus allows for convenient transfection 
of cloned DNAs into HSFs, and will now permit 
more detailed studies of the expression of cloned 
DNAs in normal (untransformed) human cells. 
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